Can a vulvar lesion that is actually cancer produce a positive syphilis swab result, and should the patient be treated for syphilis while still undergoing definitive evaluation for vulvar cancer?

Can a Vulvar Lesion That Is Actually Cancer Produce a False-Positive Syphilis Swab Result?

No, a vulvar lesion that is actually cancer should not produce a false-positive syphilis swab result, and the positive syphilis swab indicates true syphilis infection that requires treatment while simultaneously pursuing definitive evaluation for potential malignancy.

Understanding the Diagnostic Situation

The clinical scenario you describe—where a suspected vulvar cancer lesion tests positive for syphilis—most likely represents one of two possibilities:

Most Likely: True Syphilis Infection

• Syphilis is the "great imitator" and can clinically mimic vulvar malignancy, particularly in its secondary and tertiary stages 1, 2
• Darkfield examination and direct fluorescent antibody tests of lesion exudate are the definitive methods for diagnosing early syphilis and detect the actual organism Treponema pallidum 3
• These direct detection methods (swab tests) identify the organism itself, not antibodies, making false positives from non-syphilitic conditions extremely unlikely 3
• Recent case reports document syphilitic gummas presenting as squamous cell carcinoma of the vulva 1 and condyloma lata mimicking vulvar carcinoma 2, confirming that syphilis frequently masquerades as cancer

Less Likely: Concurrent Syphilis and Cancer

• Both conditions could coexist, as syphilis does not exclude malignancy 1, 2
• The patient requires evaluation for both diagnoses simultaneously

Critical Diagnostic Distinctions

Direct detection tests (swabs) versus serologic tests:

• Swab-based tests (darkfield microscopy, direct fluorescent antibody, PCR) detect T. pallidum organisms directly from the lesion and have high specificity 3
• These are fundamentally different from serologic tests (RPR, VDRL, treponemal antibody tests) that can have false positives from other medical conditions 3
• A positive direct detection test from a lesion swab indicates active syphilis infection at that site 3

Immediate Management Algorithm

Step 1: Treat the Syphilis Immediately

The patient should receive benzathine penicillin G 2.4 million units IM as a single dose for primary or secondary syphilis 3

• Treatment should not be delayed while awaiting cancer workup 3
• Parenteral penicillin G has been used effectively for more than 50 years to achieve clinical resolution and prevent late sequelae 3
• For penicillin-allergic patients, desensitization is required as penicillin is the only proven therapy 3

Step 2: Obtain Confirmatory Serologic Testing

• Perform both nontreponemal (RPR or VDRL) and treponemal tests (FTA-ABS or TP-PA) 3
• Nontreponemal tests should be quantitative to establish baseline titers for monitoring treatment response 3
• Both test types are required; one type alone is insufficient for diagnosis 3

Step 3: Proceed with Cancer Evaluation Concurrently

Biopsy the vulvar lesion for histopathologic examination to definitively rule out malignancy 3, 4, 5

• Any suspicious vulvar lesion should be biopsied to exclude invasion 4
• Request T. pallidum immunohistochemistry on the biopsy specimen, which can confirm syphilis and show characteristic perivascular organism distribution 6
• Syphilitic lesions show bandlike chronic plasma cell-rich inflammation at the squamous epithelium-lamina propria junction 6

Step 4: Monitor Clinical Response

• Lesions from secondary syphilis (condyloma lata) typically show dramatic improvement within 1-2 weeks of penicillin treatment 2
• If the lesion resolves rapidly after syphilis treatment, this strongly supports syphilis as the primary diagnosis 2
• If the lesion persists or progresses despite appropriate syphilis treatment, this increases suspicion for malignancy and mandates repeat biopsy 1, 2

Common Pitfalls to Avoid

Do not delay syphilis treatment while pursuing cancer workup:

• Untreated syphilis can progress to tertiary disease with serious neurologic and cardiovascular complications 3
• Treatment prevents ongoing tissue damage, although tissue reaction can result in scarring 3

Do not assume the positive swab is a false positive:

• Direct organism detection methods have high specificity 3
• Syphilis should be considered in the differential diagnosis of atypical vulvar lesions 2

Warn the patient about Jarisch-Herxheimer reaction:

• This acute febrile reaction occurs within the first 24 hours after therapy in patients with early syphilis 3
• Symptoms include fever, headache, and myalgia 3
• This reaction does not indicate treatment failure and should not prevent therapy 3

Evaluate for HIV infection:

• All patients with syphilis should be tested for HIV 3
• HIV-positive patients may have atypical presentations and require closer monitoring 3, 2

Assess for neurosyphilis if indicated:

• Consider CSF examination if there are neurologic symptoms or signs of tertiary syphilis 3

Partner Management

Sexual partners exposed within 90 days preceding diagnosis should be treated presumptively even if seronegative 3

Follow-Up Strategy

• Repeat quantitative nontreponemal tests at 6 and 12 months to document treatment response 3
• A fourfold decline in titer (two dilutions) demonstrates adequate treatment response 3
• Continue cancer surveillance as clinically indicated based on biopsy results and lesion behavior 3, 4